Basic Information
RNALocate ID: | RLID:11000916 |
RNA Symbol: | hsa-miR-30a-3p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-30a-star |
RNA ID: | miRBase:MIMAT0000088 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001384 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001385 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:11000914 | Exosome | Brain tissue | 23382797 |
RLID:11000915 | Exosome | Plasma | 23663360 |
RLID:11000917 | Microvesicle | Follicular fluid | 23666971 |
RLID:11000918 | Microvesicle | Serum | 24797360 |
RLID-D:11000024 | Exosome | Breast milk|Endothelial cells|Epithelial cells|Tongue tissue | |
RLID-D:11000287 | Microvesicle | Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-30a-3p | Splenic marginal zone lymphoma | MNDR-E-MI-36588 |
MNDR | hsa-miR-30a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-36589 |
MNDR | hsa-miR-30a-3p | Oral squamous cell carcinoma | MNDR-E-MI-36590 |
MNDR | hsa-miR-30a-3p | Large cell neuroendocrine cancer | MNDR-E-MI-36591 |
MNDR | hsa-miR-30a-3p | Ovarian clear cell carcinoma | MNDR-E-MI-36592 |
MNDR | hsa-miR-30a-3p | Lymphoma | MNDR-E-MI-36593 |
MNDR | hsa-miR-30a-3p | Lymphoma non-hodgkin | MNDR-E-MI-36594 |
MNDR | hsa-miR-30a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-36595 |
MNDR | hsa-miR-30a-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-36596 |
MNDR | hsa-miR-30a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-36597 |
MNDR | hsa-miR-30a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-36598 |
MNDR | hsa-miR-30a-3p | Her2-receptor positive breast cancer | MNDR-E-MI-36599 |
MNDR | hsa-miR-30a-3p | Niemann-pick disease type c | MNDR-E-MI-36600 |
MNDR | hsa-miR-30a-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-36601 |
MNDR | hsa-miR-30a-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-36602 |
MNDR | hsa-miR-30a-3p | Dermatomyositis | MNDR-E-MI-36603 |
MNDR | hsa-miR-30a-3p | Prostate cancer | MNDR-E-MI-36604 |
MNDR | hsa-miR-30a-3p | Gastric cancer | MNDR-E-MI-36605 |
MNDR | hsa-miR-30a-3p | Gastric lymphoma | MNDR-E-MI-36606 |
MNDR | hsa-miR-30a-3p | Alzheimer disease | MNDR-E-MI-36607 |
MNDR | hsa-miR-30a-3p | Bladder cancer | MNDR-E-MI-36608 |
MNDR | hsa-miR-30a-3p | Esophageal carcinoma | MNDR-E-MI-36609 |
MNDR | hsa-miR-30a-3p | Distal muscular dystrophy | MNDR-E-MI-36610 |
MNDR | hsa-miR-30a-3p | Duchenne muscular dystrophy | MNDR-E-MI-36611 |
MNDR | hsa-miR-30a-3p | Seizures | MNDR-E-MI-36612 |
MNDR | hsa-miR-30a-3p | Head and neck cancer | MNDR-E-MI-36613 |
MNDR | hsa-miR-30a-3p | Huntington disease | MNDR-E-MI-36614 |
MNDR | hsa-miR-30a-3p | Cardiovascular disease | MNDR-E-MI-36615 |
MNDR | hsa-miR-30a-3p | Lung cancer | MNDR-E-MI-36616 |
MNDR | hsa-miR-30a-3p | Parkinson disease | MNDR-E-MI-36617 |
MNDR | hsa-miR-30a-3p | Niemann-pick disease | MNDR-E-MI-36618 |
MNDR | hsa-miR-30a-3p | Basal-like breast cancer | MNDR-E-MI-36619 |
MNDR | hsa-miR-30a-3p | Thyroid cancer | MNDR-E-MI-36620 |
MNDR | hsa-miR-30a-3p | Pancreatic cancer | MNDR-E-MI-36621 |
MNDR | hsa-miR-30a-3p | Melanoma | MNDR-E-MI-36622 |
MNDR | hsa-miR-30a-3p | Rectum adenocarcinoma | MNDR-E-MI-36623 |
MNDR | hsa-miR-30a-3p | Nephroblastoma | MNDR-E-MI-36624 |
MNDR | hsa-miR-30a-3p | Colon cancer | MNDR-E-MI-36625 |
MNDR | hsa-miR-30a-3p | Ischemic attack transient | MNDR-E-MI-36626 |
MNDR | hsa-miR-30a-3p | Colon adenocarcinoma | MNDR-E-MI-36627 |
MNDR | hsa-miR-30a-3p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-36628 |
MNDR | hsa-miR-30a-3p | Familial ovarian cancer | MNDR-E-MI-36629 |
MNDR | hsa-miR-30a-3p | Prostate adenocarcinoma | MNDR-E-MI-36630 |
MNDR | hsa-miR-30a-3p | Kidney cancer | MNDR-E-MI-36631 |
MNDR | hsa-miR-30a-3p | Carcinoma ductal breast | MNDR-E-MI-36632 |
MNDR | hsa-miR-30a-3p | Glioblastoma | MNDR-E-MI-36633 |
MNDR | hsa-miR-30a-3p | Malignant glioma | MNDR-E-MI-36634 |
MNDR | hsa-miR-30a-3p | Chronic obstructive pulmonary disease | MNDR-E-MI-36635 |
MNDR | hsa-miR-30a-3p | Nemaline myopathy | MNDR-E-MI-36636 |
MNDR | hsa-miR-30a-3p | Inclusion body myositis | MNDR-E-MI-36637 |
MNDR | hsa-miR-30a-3p | Infarction middle cerebral artery | MNDR-E-MI-36638 |
MNDR | hsa-miR-30a-3p | Meningioma | MNDR-E-MI-36639 |
MNDR | hsa-miR-30a-3p | Gastric adenocarcinoma | MNDR-E-MI-36640 |
MNDR | hsa-miR-30a-3p | Lung squamous cell carcinoma | MNDR-E-MI-36641 |
MNDR | hsa-miR-30a-3p | Lung adenocarcinoma | MNDR-E-MI-36642 |
MNDR | hsa-miR-30a-3p | Adrenocortical cancer | MNDR-E-MI-36643 |
MNDR | hsa-miR-30a-3p | Thyroid carcinoma | MNDR-E-MI-36644 |
MNDR | hsa-miR-30a-3p | Bladder urothelial carcinoma | MNDR-E-MI-36645 |
MNDR | hsa-miR-30a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-36646 |
MNDR | hsa-miR-30a-3p | Carcinoma renal cell | MNDR-E-MI-36647 |
MNDR | hsa-miR-30a-3p | Clear cell renal cell carcinoma | MNDR-E-MI-36648 |
MNDR | hsa-miR-30a-3p | Large cell carcinoma | MNDR-E-MI-36649 |
MNDR | hsa-miR-30a-3p | Esophageal cancer | MNDR-E-MI-36650 |
MNDR | hsa-miR-30a-3p | Lung small cell carcinoma | MNDR-E-MI-36651 |
MNDR | hsa-miR-30a-3p | Synovial sarcoma | MNDR-E-MI-36652 |
MNDR | hsa-miR-30a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-36653 |
MNDR | hsa-miR-30a-3p | Breast invasive carcinoma | MNDR-E-MI-36654 |
MNDR | hsa-miR-30a-3p | Hepatocellular carcinoma | MNDR-E-MI-36655 |
MNDR | hsa-miR-30a-3p | Embryonal cancer | MNDR-E-MI-36656 |
MNDR | hsa-miR-30a-3p | Familiar ovarian carcinoma | MNDR-E-MI-36657 |
MNDR | hsa-miR-30a-3p | B-cell lymphoma | MNDR-E-MI-36658 |
MNDR | hsa-miR-30a-3p | Rheumatoid arthritis | MNDR-E-MI-36659 |
MNDR | hsa-miR-30a-3p | Hodgkin lymphoma | MNDR-E-MI-36660 |
MNDR | hsa-miR-30a-3p | Burkitt lymphoma | MNDR-E-MI-36661 |
MNDR | hsa-miR-30a-3p | Skin cutaneous melanoma | MNDR-E-MI-36662 |
MNDR | hsa-miR-30a-3p | Skin melanoma | MNDR-E-MI-36663 |
MNDR | hsa-miR-30a-3p | Acute myeloid leukemia | MNDR-E-MI-36664 |
MNDR | hsa-miR-30a-3p | Colorectal cancer | MNDR-E-MI-36665 |
MNDR | hsa-miR-30a-3p | Nasopharynx carcinoma | MNDR-E-MI-36666 |
MNDR | hsa-miR-30a-3p | Acute lymphocytic leukemia | MNDR-E-MI-36667 |
MNDR | hsa-miR-30a-3p | Cardiomegaly | MNDR-E-MI-36668 |
MNDR | hsa-miR-30a-3p | Nasopharyngeal cancer | MNDR-E-MI-36669 |
MNDR | hsa-miR-30a-3p | Prostatic neoplasms | MNDR-E-MI-36670 |
MNDR | hsa-miR-30a-3p | Polymyositis | MNDR-E-MI-36671 |
MNDR | hsa-miR-30a-3p | Peripheral nerve injuries | MNDR-E-MI-36672 |
MNDR | hsa-miR-30a-3p | Chronic pain | MNDR-E-MI-36673 |
MNDR | hsa-miR-30a-3p | Breast cancer her3+ negative | MNDR-E-MI-36674 |
MNDR | hsa-miR-30a-3p | Duke B | MNDR-E-MI-36675 |
MNDR | hsa-miR-30a-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-36676 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ATF3 | Homo sapiens | RR00155507 |
TOP